[Practice guideline 'Prostate cancer: diagnosis and treatment']

Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.

Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung.

[Diagnosis, treatment and follow up of prostata cancer]

Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.

A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.

Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.

Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.

The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.

A dual modality phantom for cone beam CT and ultrasound image fusion in prostate implant.

Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.

Secondary effects and biochemical control in patients with early prostate cancer treated with (125)-I seeds.

Minimally invasive surgical modalities in the management of localized prostate cancer.

The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure.

Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.

[High dose rate brachytherapy in prostate cancer in Norway]

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients.

Validation of a dose deposited by low-energy photons using GATE/GEANT4.

Quality of training in radiation oncology in Germany. Results of a 2006 survey.

Health-related quality of life in Japanese men with localized prostate cancer: assessment with the SF-8.